New York – The front of the acquisition by Pfizer pharmaceutical company Wyeth is generated in the second quarter, a profit of 1.27 billion U.S. dollars, or 94 cents per share. This corresponds to annual vision a plus of 13%. Excluding special charges of 98 cents per share earned. The consensus on Wall Street is a profit of 85 cents.
Turnover fell by 4% to 5.7 billion U.S. dollars.
As the company announced the forecast for adjusted profit of the current total to 3,48-3,58 dollars per share. Here analysts estimates a profit of $ 3.46 per share.
Author: Ezine Article BoardThis author has published 5774 articles so far.